NNC0385-0434

DRUG3 trials

Sponsors

Novo Nordisk A/S

Conditions

Atherosclerotic Cardiovascular DiseaseElevated CholesterolEstablished Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD RiskHealthy VolunteersHypercholesterolaemia

Phase 1

A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels

CompletedNCT04058834

Novo Nordisk A/SHealthy Volunteers, Hypercholesterolaemia

Start: 2019-08-20End: 2020-04-23Updated: 2021-12-30

A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men

CompletedNCT05003440

Novo Nordisk A/SAtherosclerotic Cardiovascular Disease, Healthy Volunteers

Start: 2021-08-19End: 2022-01-19Updated: 2024-01-17

A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants

CompletedNCT05091073

Novo Nordisk A/SElevated Cholesterol, Established Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD Risk, Healthy Volunteers

Start: 2021-12-09End: 2022-05-31Updated: 2023-12-26